Anbio Biotechnology Limited (NNNN) at a glance

Anbio Biotechnology Limited (NNNN) is a small-cap Healthcare company. It trades at $7.53, with a P/E of 103.9, a 74.1% profit margin and revenue growth of 73.9%. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Growth (92/100) and its weakest is Momentum (14/100).

Price

$7.53

Market cap

$684.3M

P/E ratio

103.9

Dividend yield

None

Beta

n/a

52-week range

$6.61 to $51.33